A2B adenosine receptor antagonists

Details for Australian Patent Application No. 2011202523 (hide)

Owner Gilead Palo Alto, Inc.

Inventors Elzein, Elfatih; Kalla, Rao; Marquart, Tim; Zablocki, Jeff; Xiaofen, Li

Agent Freehills

Pub. Number AU-A-2011202523

Parent 2004292529

Filing date 30 May 2011

Wipo publication date 23 June 2011

International Classifications

C07D 239/545 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 473/06 (2006.01) Heterocyclic compounds containing purine ring systems

C07D 239/54 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

16 June 2011 Complete Application Filed

23 June 2011 Application Open to Public Inspection

  Published as AU-A-2011202523

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011202524-Side wall cover

2011202522-Improved planter point